Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis.

Petraitis V, Petraitiene R, Valdez JM, Pyrgos V, Lizak MJ, Klaunberg BA, Kalasauskas D, Basevicius A, Bacher JD, Benjamin DK Jr, Hope WW, Walsh TJ.

Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01626-19. doi: 10.1128/AAC.01626-19. [Epub ahead of print]

PMID:
31591128
2.

Mid-Year Medical Knowledge Milestones and ABSITE Scores in First-Year Surgery Residents.

Cassaro S, Jarman BT, Joshi ART, Goldman-Mellor S, Hope WW, Johna S, Kaufman T, Grannan KJ; Association of Program Directors in Surgery Independent Surgery Programs Collaborative.

J Surg Educ. 2019 Sep 28. pii: S1931-7204(19)30534-3. doi: 10.1016/j.jsurg.2019.09.012. [Epub ahead of print]

PMID:
31575488
3.

Primary non-complicated midline ventral hernia: overview of approaches and controversies.

Bilezikian JA, Tenzel PL, Eckhauser FE, Hope WW.

Hernia. 2019 Sep 6. doi: 10.1007/s10029-019-02037-0. [Epub ahead of print]

PMID:
31493055
4.

Are online surgical discussion boards a safe and useful venue for surgeons to ask for advice? A review of the International Hernia Collaboration Facebook Group.

Bernardi K, Milton AN, Hope W, Roth JS, Shah SK, Shah P, Lyons NB, Martin AC, Holihan JL, Cherla DV, Ko TC, Hughes TG, Liang MK; Social Media in Surgery and Medicine Study Group.

Surg Endosc. 2019 Aug 9. doi: 10.1007/s00464-019-06895-8. [Epub ahead of print]

PMID:
31399945
5.

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.

Kovanda LL, Giamberardino C, McEntee L, Toffaletti DL, Franke KS, Bartuska A, Smilnak G, de Castro GC, Ripple K, Hope WW, Perfect JR.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00546-19. doi: 10.1128/AAC.00546-19. Print 2019 Sep.

6.

Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.

McEntee L, Johnson A, Farrington N, Unsworth J, Dane A, Jain A, Cotroneo N, Critchley I, Melnick D, Parr T, Ambrose PG, Das S, Hope W.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00603-19. doi: 10.1128/AAC.00603-19. Print 2019 Aug.

PMID:
31109982
7.

Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.

Avedissian SN, Pais GM, O'Donnell JN, Lodise TP, Liu J, Prozialeck WC, Joshi MD, Lamar PC, Becher L, Gulati A, Hope W, Scheetz MH.

J Antimicrob Chemother. 2019 Aug 1;74(8):2326-2334. doi: 10.1093/jac/dkz167.

PMID:
31065686
8.

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients.

Luque S, Hope W, Campillo N, Muñoz-Bermúdez R, Sorli L, Barceló-Vidal J, González-Colominas E, Alvarez-Lerma F, Masclans JR, Montero M, Horcajada JP, Grau S.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00378-19. doi: 10.1128/AAC.00378-19. Print 2019 Jul.

PMID:
31061150
9.

Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects.

Kovanda LL, Sullivan SM, Smith LR, Desai AV, Bonate PL, Hope WW.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00163-19. doi: 10.1128/AAC.00163-19. Print 2019 Jun.

PMID:
30988142
10.
11.

Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans.

Bulitta JB, Hope WW, Eakin AE, Guina T, Tam VH, Louie A, Drusano GL, Hoover JL.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02307-18. doi: 10.1128/AAC.02307-18. Print 2019 May. Review.

12.

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.

Ngan NTT, Mai NTH, Tung NLN, Lan NPH, Tai LTH, Phu NH, Chau NVV, Binh TQ, Hung LQ, Beardsley J, White N, Lalloo D, Krysan D, Hope W, Geskus R, Wolbers M, Nhat LTH, Thwaites G, Kestelyn E, Day J.

Wellcome Open Res. 2019 Jan 22;4:8. doi: 10.12688/wellcomeopenres.15010.1. eCollection 2019.

13.

Hernia prevention: practice patterns and surgeons' attitudes about abdominal wall closure and the use of prophylactic mesh.

Fischer JP, Harris HW, López-Cano M, Hope WW.

Hernia. 2019 Apr;23(2):329-334. doi: 10.1007/s10029-019-01894-z. Epub 2019 Feb 8.

PMID:
30734888
14.

A Preliminary Assessment of Abdominal Wall Tension in Patients Undergoing Retromuscular Hernia Repair.

Tenzel PL, Johnson RG, Bilezikian JA, Powers WF, Hope WW.

Surg Technol Int. 2019 May 15;34:251-254.

PMID:
30716161
15.

CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study.

Blassmann U, Hope W, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Briegel J, Huge V.

J Antimicrob Chemother. 2019 Apr 1;74(4):991-996. doi: 10.1093/jac/dky543.

PMID:
30689877
16.

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.

Stone NR, Rhodes J, Fisher MC, Mfinanga S, Kivuyo S, Rugemalila J, Segal ES, Needleman L, Molloy SF, Kwon-Chung J, Harrison TS, Hope W, Berman J, Bicanic T.

J Clin Invest. 2019 Mar 1;129(3):999-1014. doi: 10.1172/JCI124516. Epub 2019 Jan 28.

17.

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study.

Hope W, Johnstone G, Cicconi S, Felton T, Goodwin J, Whalley S, Santoyo-Castelazo A, Ramos-Martin V, Lestner J, Credidio L, Dane A, Carr DF, Pirmohamed M, Salim R, Neely M.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02353-18. doi: 10.1128/AAC.02353-18. Print 2019 Apr.

18.

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2019 Jan 14;20(1):48. doi: 10.1186/s13063-018-3155-9.

19.

Young adults with chronic kidney disease: An exploration of their relationships and support networks.

Coyne E, Langham H, Tomlin M, Hope W, Johnson C, Byrne C, Bebb C, Buchanan H.

J Ren Care. 2019 Mar;45(1):20-28. doi: 10.1111/jorc.12263. Epub 2018 Dec 12.

PMID:
30548454
20.

Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis".

Stott KE, Beardsley J, Kolamunnage-Dona R, Castelazo AS, Kibengo FM, Mai NTH, Tùng NLN, Cuc NTK, Day J, Hope W.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02254-18. doi: 10.1128/AAC.02254-18. Print 2018 Dec. No abstract available.

21.

Correction for Stott et al., "Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis".

Stott KE, Beardsley J, Whalley S, Mukasa Kibengo F, Mai NTH, Tùng NLN, Cuc NTK, Kolamunnage-Dona R, Hope W, Day J.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02249-18. doi: 10.1128/AAC.02249-18. Print 2018 Dec. No abstract available.

22.

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.

Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4. Erratum in: Trials. 2019 Jan 14;20(1):48.

23.

Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei.

Le T, Ly VT, Thu NTM, Nguyen A, Thanh NT, Chau NVV, Thwaites G, Perfect J, Kolamunnage-Dona R, Hope W.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01739-18. doi: 10.1128/AAC.01739-18. Print 2019 Feb.

24.

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.

Andes DR, Ghannoum MA, Mukherjee PK, Kovanda LL, Lu Q, Jones ME, Santerre Henriksen A, Lademacher C, Hope WW.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01634-18. doi: 10.1128/AAC.01634-18. Print 2019 Jan.

25.

Rationale and Technique for Measuring Abdominal Wall Tension in Hernia Repair.

Hope WW, Williams ZF, Rawles JW 3rd, Hooks WB 3rd, Clancy TV, Eckhauser FE.

Am Surg. 2018 Sep 1;84(9):1446-1449.

PMID:
30268173
26.

Prophylactic Mesh for Hernia Prevention: Has the Time Arrived?

Fox SS, Johnson R, Fischer JP, Eckhauser F, Hope WW.

Plast Reconstr Surg. 2018 Sep;142(3 Suppl):180S-186S. doi: 10.1097/PRS.0000000000004876.

PMID:
30138288
27.

Measuring Success in Complex Abdominal Wall Reconstruction: The Role of Validated Outcome Scales.

Otero J, Arnold MR, Hope WW, Augenstein VA.

Plast Reconstr Surg. 2018 Sep;142(3 Suppl):163S-170S. doi: 10.1097/PRS.0000000000004873.

PMID:
30138285
28.

Abdominal Wall Reconstruction Risk Stratification Tools: A Systematic Review of the Literature.

Bernardi K, Adrales GL, Hope WW, Keith J, Kuhlens H, Martindale RG, Melin AA, Orenstein SB, Roth JS, Shah SK, Tsuda S, Liang MK; Ventral Hernia Outcomes Collaborative Writing Group.

Plast Reconstr Surg. 2018 Sep;142(3 Suppl):9S-20S. doi: 10.1097/PRS.0000000000004833.

PMID:
30138260
29.

Prophylactic mesh used in ileal conduit formation following radical cystectomy: a retrospective cohort.

Tenzel PL, Williams ZF, McCarthy RA, Hope WW.

Hernia. 2018 Oct;22(5):781-784. doi: 10.1007/s10029-018-1801-5. Epub 2018 Aug 10.

PMID:
30097796
30.

Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.

Cojutti PG, Lugano M, Righi E, Della Rocca G, Bassetti M, Hope W, Pea F.

Eur J Clin Pharmacol. 2018 Nov;74(11):1449-1459. doi: 10.1007/s00228-018-2526-1. Epub 2018 Jul 21.

PMID:
30032414
31.

Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies.

Cojutti PG, Candoni A, Lazzarotto D, Rabassi N, Fanin R, Hope W, Pea F.

Br J Clin Pharmacol. 2018 Nov;84(11):2544-2550. doi: 10.1111/bcp.13707. Epub 2018 Aug 19.

PMID:
29975796
32.

Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.

Jarvis JN, Leeme TB, Molefi M, Chofle AA, Bidwell G, Tsholo K, Tlhako N, Mawoko N, Patel RKK, Tenforde MW, Muthoga C, Bisson GP, Kidola J, Changalucha J, Lawrence D, Jaffar S, Hope W, Molloy SLF, Harrison TS.

Clin Infect Dis. 2019 Jan 18;68(3):393-401. doi: 10.1093/cid/ciy515.

33.

Pharmacokinetics-pharmacodynamics of antifungal agents in the central nervous system.

Stott KE, Hope W.

Expert Opin Drug Metab Toxicol. 2018 Aug;14(8):803-815. doi: 10.1080/17425255.2018.1492551. Epub 2018 Jul 9. Review.

PMID:
29943650
34.

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis.

Stott KE, Beardsley J, Kolamunnage-Dona R, Castelazo AS, Kibengo FM, Mai NTH, Tùng NLN, Cuc NTK, Day J, Hope W.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00885-18. doi: 10.1128/AAC.00885-18. Print 2018 Sep. Erratum in: Antimicrob Agents Chemother. 2018 Nov 26;62(12):.

35.

Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.

Kovanda LL, Walsh TJ, Benjamin DK Jr, Arrieta A, Kaufman DA, Smith PB, Manzoni P, Desai AV, Kaibara A, Bonate PL, Hope WW.

Pediatr Infect Dis J. 2018 Jun;37(6):580-585. doi: 10.1097/INF.0000000000001957.

36.

Umbilical Hernia Repair: Overview of Approaches and Review of Literature.

Appleby PW, Martin TA, Hope WW.

Surg Clin North Am. 2018 Jun;98(3):561-576. doi: 10.1016/j.suc.2018.02.001. Epub 2018 Mar 12. Review.

PMID:
29754622
37.

Role of Prophylactic Mesh Placement for Laparotomy and Stoma Creation.

Rhemtulla IA, Messa CA 4th, Enriquez FA, Hope WW, Fischer JP.

Surg Clin North Am. 2018 Jun;98(3):471-481. doi: 10.1016/j.suc.2018.01.003. Review.

PMID:
29754617
38.

Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.

Stott KE, Beardsley J, Whalley S, Kibengo FM, Mai NTH, Tùng NLN, Cuc NTK, Kolamunnage-Dona R, Hope W, Day J.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e02526-17. doi: 10.1128/AAC.02526-17. Print 2018 Jul. Erratum in: Antimicrob Agents Chemother. 2018 Nov 26;62(12):.

39.

Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance.

Cojutti PG, Barbarino C, De Monte A, Hope W, Pea F.

Eur J Clin Pharmacol. 2018 Aug;74(8):1091-1092. doi: 10.1007/s00228-018-2465-x. Epub 2018 Apr 29. No abstract available.

PMID:
29705821
40.

Contemporary concepts in hernia prevention: Selected proceedings from the 2017 International Symposium on Prevention of Incisional Hernias.

Harris HW, Hope WH, Adrales G, Andersen DK, Deerenberg EB, Diener H, Dumanian G, East B, Fischer JP, Ureña MAG, Gibeily GJ, Hansson BM, Hernández-Granados P, Hiles MC, Jeekel J, Levinson H, Lopez-Cano M, Muysoms F, Pereira JA, Prudhomme M, Ramaswamy A, Stabilini C, Torkington J, Valverde S, Young DM.

Surgery. 2018 Aug;164(2):319-326. doi: 10.1016/j.surg.2018.02.020. Epub 2018 Apr 25.

PMID:
29705098
41.

Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli.

Merino-Bohórquez V, Docobo-Pérez F, Sojo J, Morales I, Lupión C, Martín D, Cameán M, Hope W, Pascual Á, Rodríguez-Baño J.

Clin Microbiol Infect. 2018 Nov;24(11):1177-1183. doi: 10.1016/j.cmi.2018.02.005. Epub 2018 Apr 10.

PMID:
29649596
42.

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.

Benjamin DK Jr, Kaufman DA, Hope WW, Smith PB, Arrieta A, Manzoni P, Kovanda LL, Lademacher C, Isaacson B, Jednachowski D, Wu C, Kaibara A, Walsh TJ.

Pediatr Infect Dis J. 2018 Oct;37(10):992-998. doi: 10.1097/INF.0000000000001996. Erratum in: Pediatr Infect Dis J. 2018 Nov;37(11):1198.

43.

Exploring the Use of C-Reactive Protein to Estimate the Pharmacodynamics of Vancomycin.

Rawson TM, Charani E, Moore LSP, Gilchrist M, Georgiou P, Hope W, Holmes AH.

Ther Drug Monit. 2018 Jun;40(3):315-321. doi: 10.1097/FTD.0000000000000507.

44.

Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis.

Box H, Negri C, Livermore J, Whalley S, Johnson A, McEntee L, Alastruey-Izquierdo A, Meis JF, Thornton C, Hope W.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02516-17. doi: 10.1128/AAC.02516-17. Print 2018 May.

45.

Reducing Early Readmissions after Ventral Hernia Repair with the Americas Hernia Society Quality Collaborative.

Poulose BK, Harris DA, Phillips S, Janczyk RJ, Yunis J, Voeller GR, Carbonell A, Warren J, Stoikes N, Webb D, Hope WW, Rosen MJ; Americas Hernia Society Quality Collaborative.

J Am Coll Surg. 2018 May;226(5):814-824. doi: 10.1016/j.jamcollsurg.2018.01.048. Epub 2018 Feb 8.

PMID:
29428233
46.

Incisional Hernia in the United States: Trends in Hospital Encounters and Corresponding Healthcare Charges.

Shubinets V, Fox JP, Lanni MA, Tecce MG, Pauli EM, Hope WW, Kovach SJ, Fischer JP.

Am Surg. 2018 Jan 1;84(1):118-125.

PMID:
29428038
47.

Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers.

Felton TW, Ogungbenro K, Boselli E, Hope WW, Rodvold KA.

J Antimicrob Chemother. 2018 May 1;73(5):1340-1347. doi: 10.1093/jac/dkx541.

PMID:
29385448
48.

Clinical and Patient-Reported Outcomes after Absorbable Strap Fixation for Ventral Hernia Repair.

Bougard H, Bringman S, Hope WW, Redan JA, Doerhoff C, Chudy M, Romanowski C, Jones PC.

Surg Technol Int. 2017 Dec 22;31:83-92.

PMID:
29315451
49.

Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.

Nixon GL, McEntee L, Johnson A, Farrington N, Whalley S, Livermore J, Natal C, Washbourn G, Bibby J, Berry N, Lestner J, Truong M, Owen A, Lalloo D, Charles I, Hope W.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01909-17. doi: 10.1128/AAC.01909-17. Print 2018 Apr.

50.

Comparison of hernia registries: the CORE project.

Kyle-Leinhase I, Köckerling F, Jørgensen LN, Montgomery A, Gillion JF, Rodriguez JAP, Hope W, Muysoms F.

Hernia. 2018 Aug;22(4):561-575. doi: 10.1007/s10029-017-1724-6. Epub 2018 Jan 6. Review.

Supplemental Content

Support Center